Produces Interferon α-2-leukocyte Vetom  1. 23 (1. 1) (strain VKPM B 7092) - used for the correction of immunodeficiency states not formed due to HIV infection, the drug restores and preserves the intestinal microbial community during dysbacteriosis, also after a course of antibiotic treatment. Suitable as an additional remedy for the treatment of herpes (genital, shingles, etc.)), encephalitis, influenza and ARVI (acute respiratory viral infections), cytomegalovirus infections.  How to use Vetom and its features - Link to information 

  To improve immune status -

    It is used in patients with malignant tumors for prophylactic purposes, to reduce the toxic effect of chemotherapy, radiation therapy, as a general tonic and detoxifying agent that restores the body's antitumor resistance.Normalizes the level of bilirubin, transaminases and other enzymes in the blood, increases appetite and general body tone in viral hepatitis A, B and C.
    Can be used in the treatment of hairy cell leukemia, chronic myeloid leukemia, multiple myeloma, kidney cancer, AIDS-related Kaposi's sarcoma, mycosis fungoides, reticulosarcoma, colorectal cancer, lung cancer, breast cancer, and other types of cancer.
It is used as an additional remedy for infectious diarrhea, treatment of urethritis, gastric and duodenal ulcers, respiratory diseases, asthma, allergies, radiation sickness, myasthenia gravis, multiple sclerosis, barrel disease. After taking the drug, the degree and speed of alcohol intoxication when drinking alcoholic beverages is significantly reduced.

Vetom 1.23 are a liquid nutrient medium after growing bacteria Bacillus subtilis strain VKPM B-10641 (DSM 24613). In appearance, the preparations are a light brown liquid with a characteristic ammonia odor.Possible presence of insoluble sediment. The healing effect is ensured by the properties of the bacteria Bacillus subtilis recombinant strain VKPM B-10641 (DSM 24613), which, multiplying mainly in the large intestine, secrete: proteolytic, amylolytic, cellulolytic enzymes; human leukocyte interferon -2; bacitracins, which suppress the growth and development of pathogenic and opportunistic microflora; other biologically active substances.As a result of this process, the microbial composition of the intestine is transformed to correspond to the evolutionarily established norm, its walls are cleansed of indigestible food debris, which promotes the active removal of toxins from the body and the unhindered delivery of biologically active and nutrients.

Under the influence of Vetom 1.23 are normalized: metabolism, digestion and absorption of biologically active food components in the gastrointestinal tract. Scope of application: used as an additional source of probiotic microorganisms to improve the health of the human body. Method of administration and dosage: Vetom is used orally. The frequency of administration is directly dependent on the state of the human body.It is recommended to take for 10 days during or after meals with a small amount of water, juice or tea. Release form: 10 ml bottles made of polymer materials dosed with a pipette or penicillin glass bottles with a sealed rubber cap. Shelf life - 2 years from the date of manufacture. Store at temperatures from 0 to 10 °C. (In the refrigerator)

About coronavirus.

Analysis of the results of assessing the antiviral activity of interferon alpha-2  human recombinant based on a study of its total virus-inhibitory effect on a model of coronavirus infection in cell culture.
Retrospective analysis of data from a report on the results of a study of the total virus-inhibitory effect of human recombinant interferon alpha-2beta, conducted by the Influenza Research Institute of the Russian Academy of Medical Sciences on a model of coronavirus infection in cell culture under control of the purity of the coronavirus isolate used at each stage using electron microscopy (negative contrast).
 The controls were: a cell culture infected with a virus (positive control) and an intact cell culture, into which a supporting medium was added instead of solutions of the test substances (negative control). As a result, it was revealed that interferon alpha-2  the human recombinant suppressed both the direct replication of the coronavirus in culture and reduced the infectivity of the viral progeny.The chemotherapy index of the drug is at least 10, which is a relatively high indicator for chemotherapy drugs.  
Interferon alpha-2  human recombinant for human coronavirus infection can be considered as one of the promising means in prevention and therapy.
Coronaviruses (CoV) belong to the genus Alphacoronavirus and Betacoronavirus (order Nidovirales, family Coronaviridae, subfamily Coronavirinae) and are capable of infecting a wide range of mammals, including humans.
 Known human coronaviruses (HCoVs): HCoV-HKU1, HCoV-229E, HCoV-NL63, and HCoV-OC43 typically cause mild to moderate respiratory tract infection; however, in some patients the course of the disease may be more severe.  In 2002-2003.An epidemic of severe lower respiratory tract infection with a mortality rate of -10% was caused by the severe acute respiratory syndrome virus (SARS). In 2012, another coronavirus caused severe human respiratory disease in the Arabian Peninsula and was named Middle East respiratory syndrome (MERS) coronavirus.
 Drugs that generate interferon alpha-2  human recombinant – Gripoferon, Vetom 1. 1,  Vetom 1. 23.

 

.